Pfizer Inc
Stocks making the biggest moves premarket: FedEx, GameStop, Moderna and more
Check out the companies making headlines before the bell: FedEx (FDX) – FedEx earned an adjusted $4.59 per share for its latest quarter, missing estimates by 5 cents, though the delivery service’s revenue beat analyst forecasts. FedEx’s bottom line was impacted by worker shortages stemming from the Covid-19 omicron variant outbreak during the quarter. FedEx […]
Read More
Moderna seeks FDA authorization for 4th dose of Covid shot
Illustration of a vial of Moderna vaccine for coronavirus treatment. Marcos Del Mazo | Lightrocket | Getty Images Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its Covid-19 vaccine as a booster dose for all adults. The request is broader than rival pharmaceutical company Pfizer’s request earlier […]
Read More
Moderna CEO Stephane Bancel has sold more than $400 million of company stock during the pandemic
Moderna CEO Stephane Bancel Steven Ferdman | Getty Images Moderna CEO Stephane Bancel has sold $408 million in company stock since the beginning of the coronavirus pandemic — averaging roughly $3.6 million a week — as the company’s stock soared on the development and rollout of its Covid vaccine, according to CNBC’s analysis of the […]
Read More
Stocks making the biggest moves premarket: Nvidia, Boeing, Micron and others
Check out the companies making headlines before the bell: DiDi Global (DIDI), Alibaba (BABA), JD.com (JD), Pinduoduo (PDD) – China-based stocks listed in the U.S. are staging strong rallies in premarket trading, helped by state media reports that the Chinese government will take steps to support the markets and the economy, and that the U.S. […]
Read More
White House says U.S. will run out of money to fight pandemic if Congress doesn’t pass Covid funding bill
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The White House on Tuesday warned the U.S. won’t have enough booster shots and lifesaving Covid treatments for Americans if […]
Read More
Covid was declared a pandemic two years ago and now we’re finally moving on — but public health experts say it’s not over
Medical staff treat a coronavirus disease (COVID-19) patient in the Intensive Care Unit (ICU) at the Providence Mission Hospital in Mission Viejo, California, January 25, 2022. Shannon Stapleton | Reuters LONDON — With war raging between Russia and Ukraine, the world’s battle against the coronavirus has been largely sidelined and the second anniversary of Covid-19 […]
Read More
Vaccine maker stocks rise as China battles worst Covid outbreak since 2020
Shares of the major vaccine makers rose on Monday as China battles its worst Covid outbreak since 2020, fueling fear that the pandemic will drag on which could drive demand for future vaccine orders. Moderna‘s stock jumped more than 8% to close at $150.07. In the morning, the biotech company’s stock had surged nearly 20% […]
Read More
Dr. Gottlieb says China is ‘very vulnerable’ to omicron subvariant spread despite ‘zero-Covid policy’
Low levels of natural immunity are complicating China’s efforts to limit spread during its recent surge in cases of the new Covid omicron BA.2 subvariant, Dr. Scott Gottlieb told CNBC on Monday. “China has a population that’s very vulnerable to this new variant. This is a much more contagious variant, it’s going to be harder […]
Read More
Two years into the coronavirus pandemic, Fauci hopes the world will not forget lessons from a ‘catastrophic experience’
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, arrives for a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to COVID-19, at the U.S. Capitol in Washington, D.C., May 11, 2021. Greg Nash | Pool | Reuters As the two-year anniversary of the coronavirus […]
Read More
Pfizer planning to submit data on 4th Covid shot soon, while working on vaccine for all variants
Pfizer plans to submit data to the Food and Drug Administration for a fourth Covid shot soon, and it’s working on a vaccine that protects against all coronavirus variants, CEO Albert Bourla told CNBC on Friday. “I think we’re going to submit to FDA a significant progress of data about the need for a fourth […]
Read More